ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,254Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 1111

$1.63M Total Retail Price of All Prescriptions

Rank: 10 out of 1111

771 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 771 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

30% of this provider’s 771 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

1% of this provider’s 23,895 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 1,217 1,048 S3 1 1
LEVOTHYROXINE SODIUM 1,119 1,021 2 3
OMEPRAZOLE 945 880 3 4
LISINOPRIL 784 689 4 2
FUROSEMIDE 690 623 5 6
NAMENDA 645 623 6 31
POTASSIUM CHLORIDE 629 571 7 9
SIMVASTATIN 557 489 8 5
CITALOPRAM HBR 554 498 9 14
AMLODIPINE BESYLATE 536 492 10 7
GABAPENTIN 531 475 11 10
CYMBALTA 477 416 12 40
WARFARIN SODIUM 474 414 13 19
DIVALPROEX SODIUM 435 385 14 82
DONEPEZIL HCL 432 406 15 25
POLYETHYLENE GLYCOL 3350 406 398 16 45
METOPROLOL TARTRATE 350 286 17 12
METFORMIN HCL 307 243 18 8
TAMSULOSIN HCL 303 270 19 28
RISPERIDONE 273 247 20 60
CARVEDILOL 271 246 21 21
LANTUS 268 242 22 46
HYDROCHLOROTHIAZIDE 267 236 23 11
SERTRALINE HCL 266 238 24 24
PRAVASTATIN SODIUM 251 191 25 17
JANTOVEN 229 229 26 156
MIRTAZAPINE 217 191 27 52
ZOLPIDEM TARTRATE 208 157 28 16
CLOPIDOGREL 206 191 29 30
ATENOLOL 205 169 30 22
GLIPIZIDE 197 183 31 57
METOPROLOL SUCCINATE 192 178 32 20
ATORVASTATIN CALCIUM 189 167 33 15
HUMULIN R 185 161 34 189
TRAMADOL HCL 180 168 35 13
OXYBUTYNIN CHLORIDE ER 178 148 36 114
FAMOTIDINE 170 141 37 77
CLONIDINE HCL 167 150 38 42
EXELON 159 159 39 121
DIGOXIN 155 151 40 47
LEVETIRACETAM 154 143 41 111
NYSTOP 150 110 42 175
CARBIDOPA-LEVODOPA 138 138 43 101
ISOSORBIDE MONONITRATE ER 135 130 44 73
PANTOPRAZOLE SODIUM 134 106 45 50
PLAVIX 134 125 45 49
TRAZODONE HCL 130 103 47 32
MELOXICAM 128 113 48 18
IPRATROPIUM-ALBUTEROL 127 120 49 161
ESCITALOPRAM OXALATE 127 118 49 78
QUETIAPINE FUMARATE 125 108 51 76
NEXIUM 124 109 52 26
FLUTICASONE PROPIONATE 120 114 53 27
KLOR-CON M10 119 114 54 144
ALLOPURINOL 116 87 55 36
DIOVAN 114 114 56 51
FLUOXETINE HCL 108 83 57 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 108 85 57 23
ROPINIROLE HCL 105 102 59 68
MORPHINE SULFATE ER 103 74 S2 60 74
VENLAFAXINE HCL ER 102 89 61 105
LEVEMIR 101 74 62 132
RANITIDINE HCL 99 84 63 29
ALENDRONATE SODIUM 99 89 63 35
LOPERAMIDE 99 95 63 165
LIDODERM 95 92 66 198
SANTYL 94 86 67 179
NOVOLIN R 93 85 68 142
CIPROFLOXACIN HCL 88 80 69 58
OLANZAPINE 87 75 70 117
LOSARTAN POTASSIUM 86 76 71 34
SPIRONOLACTONE 85 70 72 83
CEPHALEXIN 83 71 73 89
BUSPIRONE HCL 82 64 74 96
DIVALPROEX SODIUM ER 81 81 75 171
HALOPERIDOL 78 55 76 180
CRESTOR 77 66 77 33
AMIODARONE HCL 76 76 78 145
BACLOFEN 75 47 79 119
KLOR-CON M20 75 71 79 79
DILTIAZEM ER 73 57 81 158
TRIAMCINOLONE ACETONIDE 72 69 82 128
ALBUTEROL SULFATE 72 69 82 136
FINASTERIDE 72 61 82 115
SPIRIVA 72 69 82 53
CLONIDINE 72 72 82 221
FENTANYL 70 41 S2 87 65
HYDRALAZINE HCL 68 63 88 155
PAROXETINE HCL 66 49 89 55
HYDROCORTISONE 66 64 89 292
CELEBREX 65 44 91 81
MEGESTROL ACETATE 65 60 R 91 103
LOSARTAN-HYDROCHLOROTHIAZIDE 64 64 93 72
AMLODIPINE BESYLATE-BENAZEPRIL 63 57 94 67
NOVOLOG 60 59 95 104
ABILIFY 60 45 95 123
PROPRANOLOL HCL 60 60 95 124
THIORIDAZINE HCL 59 12 R 98 395
SULFAMETHOXAZOLE-TRIMETHOPRIM 59 56 98 71
NYSTATIN 59 55 98 151
TRAVATAN Z 57 57 101 183
ADVAIR DISKUS 57 56 101 43
PROMETHAZINE HCL 57 48 R 101 69
CARBAMAZEPINE 54 0 104 196
TIZANIDINE HCL 54 40 104 91
PRADAXA 54 54 104 247
JANUVIA 54 30 104 75
NITROFURANTOIN MONO-MACRO 53 50 108 149
PHENYTOIN SODIUM EXTENDED 53 38 108 126
SEROQUEL 52 46 110 170
CYCLOBENZAPRINE HCL 51 24 R 111 37
PREDNISONE 51 40 111 48
ESTRADIOL 51 34 R 111 102
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.